Contact

Open Field 98 Home About Services Federal Status State-by-State Map Access & Research Paths Contact Federal law · state developments · practical boundaries Ibogaine Legality USA: Federal And State Status Ibogaine remains illegal under federal law in the United States. The details matter: Schedule I status, state laws, limited research permissions, and international treatment pathways each carry different legal implications. Current legal status Research context Harm-aware guidance The central rule Federal classification of ibogaine Ibogaine is a psychoactive substance derived from the iboga plant, an African shrub known as Tabernanthe iboga . Its active ingredient has been discussed for possible therapeutic uses, but discussion of potential benefits does not change federal law. Schedule I controlled substance The Drug Enforcement Administration classifies ibogaine as a Schedule I controlled substance under the Controlled Substances Act. The DEA drug scheduling framework places Schedule I substances in the most restrictive drug schedule. No general medical use Under federal law, ibogaine has no currently accepted medical use in treatment in the United States and no FDA approval. That means ibogaine treatment is illegal outside authorized research purposes. One nationwide baseline The federal government prohibits manufacture, personal possession, and distribution for non-research purposes. State level policy may alter local enforcement priorities, but it cannot override the federal classification of a controlled substance. The Controlled Substances Act, enacted in 1970, placed ibogaine alongside substances such as heroin, LSD, and ecstasy because of its psychoactive properties and lack of accepted medical use. The current legislative landscape reflects ongoing efforts to expand research, not a general legalization of ibogaine treatment. Access is not authorization Impact of Schedule I status Schedule I status affects every stage of ibogaine treatment and research.

Published channels